Market access and pricing
How will payers and HTA bodies judge the asset, and what does that do to price and uptake?
The HTA and payer framework in each market, how comparable drugs were assessed, the evidence a submission needs, and the consequence for price and access.
Yes. The library holds Gulf payer and HTA analyses built on the SFDA registration and pricing framework and the tender and insurance channels of each market.